References for recent review articles about cationic antimicrobial peptides:
Ganz T. Defensins and other antimicrobial peptides: a historical perspective and an update. Comb Chem High Throughput Screening 2005, 8, 209-17. Lehrer RI. Primate defensins. Nature Revs Micro 2004, 2, 727-738. Yang D,
Biragyn A, Hoover DM et al. Multiple roles of antimicrobial defensins, cathelicidins and eosinophil-derived neurotoxin in host defence. Ann Rev Immunol, 2004, 22,181-215.
Boman HG. Anteribacterial peptides: basic facts and emerging concepts. J Internal Med 2003, 254, 197-215. Zaiou M and GalloRL. Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med 2002, 80, 549-561.
Recent publications about cationic antimicrobial peptides at the ocular surface:
Narayanan S, Manning J, Proske R, McDermott AM. (2006) The effect of hyperosmolality on b-defensin gene expression by human corneal epithelial cells. In Press Cornea
Huang LC, Petkova TD, Reins RY, Proske RJ and McDermott AM. Multi-functional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci. 2006, 47, 2369-2380.
McDermott AM, RichD, Cullor J, Mannis MJ, Smith W, Reid T, Murphy CJ. The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears Br. J. Ophthalmol2006, 90, 609-611.
Gordon YJ, Romanoswki EG, McDermottAM. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 2005, 30, 505-515.
Gordon YJ, HuangLH, Romanowski EG, Yates KA, Proske RJ, McDermott AM. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res 2005, 30,385-394.
Huang LC, Jean D,McDermott AM. Effect of preservative free artificial tears on the antimicrobial activity of human b-defensin-2 and Cathelicidin LL-37 in vitro. Eye Contact Lens, 2005, 31, 34-38.
McDermott AM. Defensins and other antimicrobial peptides at the ocular surface. The OcularSurface, 2004, 2, 229-247. NarayananS, Miller WL and McDermottAM. Expression of humanb-defensins in conjunctival epithelium: relevance to dry eye disease. Invest. Ophthalmol.Vis. Sci., 2003, 44, 3795-3801.
McDermottAM, Redfern RL, Zhang B, Pei Y, Huang L and Proske RJ. Defensin expression by the cornea: multiple signaling pathways mediate IL-1b stimulation of hBD-2 expression by human corneal epithelial cells. Invest. Ophthalmol. Vis.Sci., 2003, 44, 1859-1865.
McDermott AM,Redfern RL, Zhang B. Human b-defensin 2 is upregulated during re-epithelialization of the cornea. Curr Eye Res. 2001;22:64-67.
Recent publications by other researchers interested in cationic antimicrobial peptides at the ocular surface:
Rodriguez-MartinezS, Cancino-Diaz ME, Cancino-Diaz JC. Expression of CRAMP via PGN-TLR-2 and of alpha-defensin-3via CpG-ODN-TLR-9 in corneal fibroblasts. Br J Ophthalmol. 2006, 90, 378-82.
Ikeda A, NakanishiY, Sakimoto T, Shoji J, Sawa M, Nemoto N. Expression of beta defensins in ocular surface tissue of experimentally developed allergic conjunctivitis mouse model. Jpn J Ophthalmol. 2006, 50, 1-6.
Kumar A, Zhang J,Yu FS. Toll-likereceptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells. Microbes Infect. 2006, 8, 380-9.